ArticleClinical and translational science2024

Long-term benefit of SGLT2 inhibitors to prevent heart failure hospitalization in patients with diabetes, with potential time-varying benefit.

Yasuo Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.